New streamlined arrangements for blood clotting factor concentrate products
The Government has recently approved the drafting of legislation to transfer responsibility for procurement of clotting factor concentrate products, used in the treatment of haemophilia and other clotting factor disorders, from the Irish Blood Transfusion Service (IBTS) to St James’s Hospital, where the National Haemophilia Centre is based.
Agreement has been reached between the IBTS, St James’s and the HSE on the transfer arrangements. The Irish Haemophilia Society is also supportive of this change. The legislation will be drafted as a priority since the new arrangements will result in a more streamlined system of procurement for the products and will also achieve significant financial savings for the health budget in relation to their purchase.